22:03 , Sep 18, 2017 |  BC Extra  |  Company News

Management tracks: Kamada, Vertex, Addex, Achillion

Orphan disease company Kamada Ltd. (Tel Aviv:KMDA; NASDAQ:KMDA) said Deputy CEO and CFO Gil Efron will leave at the end of the year. Chaime Orlev will become CFO, effective Jan. 1, 2018. Orlev was CFO...
00:42 , Jul 9, 2015 |  BC Extra  |  Politics & Policy

White House issues privacy guidelines for precision medicine

The White House released an update Wednesday on the progress of its Precision Medicine Initiative (PMI) that included proposed privacy guidelines and a series of data-sharing partnerships. In draft guidelines, the White House emphasized transparency...
08:00 , Dec 18, 2014 |  BC Innovations  |  Translation in Brief

YABAO GOES BOLD

Yabao goes bold China-based Yabao Pharmaceutical Group Co. Ltd. and MRC Technology are jointly going where Western pharmas and academics fear to tread with a preclinical partnership to develop compounds against an undisclosed kinase target...
08:00 , Dec 8, 2014 |  BC Week In Review  |  Company News

Medgenics, The Children’s Hospital of Philadelphia deal

The Center for Applied Genomics (CAG) at The Children’s Hospital of Philadelphia (CHOP) granted Medgenics a four-year, exclusive, worldwide license to the CAG biobank to identify pediatric rare and orphan disease targets and therapies. The...
07:00 , Apr 15, 2013 |  BC Week In Review  |  Company News

HMR news

HMR opened the Center for Applied Genomics Research (Martinsried, Germany). The center will focus on treatments for Alzheimer's disease, osteoarthritis, bacterial infections and certain cardiovascular diseases. The center's activities will be coordinated with HMR's joint...
08:00 , Jan 5, 2012 |  BC Innovations  |  Targets & Mechanisms

Fine-tuning mGluRs

Studies by two American teams have converged on a family of metabotropic glutamate receptors as players in attention deficit hyperactivity disorder and autism spectrum disorder. 1,2 The findings build an argument for agonizing the receptors...
07:00 , Aug 2, 2010 |  BC Week In Review  |  Clinical News

InsightDx Mammostrat test: Pivotal trial data

A pivotal trial in 1,540 patients showed that higher Mammostrat scores were significantly associated with reduced distant recurrence-free survival, relapse-free survival and OS in estrogen receptor-positive breast cancer (p<0.00001). Data were published in Breast Cancer...
07:00 , Jun 24, 2010 |  BC Innovations  |  Targets & Mechanisms

Common ground in autism and epilepsy

A pair of studies has identified rare genomic copy number variants associated with both autism and epilepsy, suggesting there might be common mechanisms behind both diseases. 1,2 The most immediate application of the findings could...
07:00 , Jun 3, 2010 |  BC Innovations  |  Distillery Techniques

Technology: Markers

Markers Gene expression-based classifier for late renal transplant failure prediction A study in humans identified a gene expression signature that could help predict late kidney transplant failure. In kidney biopsies from 105 patients who experienced...
07:00 , Jun 3, 2010 |  BC Innovations  |  Tools & Techniques

Learning from failure

Transplanted kidneys live on borrowed time, with many grafts eventually succumbing to immune attack or recurrence of the original kidney disease. Now, a gene expression study by a Canadian team has identified a set of...